Coronary CT Angiography for Flow and Soft Plaque Assessment
Yes, coronary CT angiography should be performed as the preferred first-line test to evaluate coronary artery disease, including assessment of soft (non-calcified) plaques, particularly in patients with stable chest pain. 1
Primary Recommendation
The most recent guidelines from the UK and European societies, along with evidence from major trials like SCOT-HEART, establish coronary CTA as the preferred initial test for patients with suspected coronary artery disease 1. This represents a fundamental shift from traditional functional testing (stress tests, nuclear imaging) to anatomic assessment.
Key Supporting Evidence
The coronary CTA-first strategy provides several critical advantages:
- Does not increase cardiac catheterizations or revascularizations compared to functional testing 1
- Reduces costs compared to stress imaging strategies 1
- Improves long-term outcomes through increased use of preventive therapies when patients learn they have plaque 1
- In SCOT-HEART, knowledge of plaque presence led to significant reduction in death and nonfatal myocardial infarction over 5-year follow-up 1
Soft Plaque Detection Capabilities
Current Technical Performance
Coronary CTA can detect and characterize non-calcified (soft) plaques, though with important limitations 2:
Sensitivity for plaque types:
- Calcific plaques: 95%
- Hypo-echoic (soft) plaques: 78%
- Hyperechoic plaques: 78%
- Specificity: 92% 2
Critical Technical Limitations
The distinction between fibrous and soft plaques remains problematic due to overlapping CT density values 2. Current MDCT resolution (750 µm) is approximately 10 times larger than the thin fibrous cap (70 µm) that characterizes vulnerable plaques 2.
Important caveats:
- Optimal image quality not achieved in 15% of vessels 2
- Smaller plaques in smaller vessels are not accurately characterized 2
- Interobserver variability for plaque volume measurements can be as high as 37% 2
- Assessment limited to studies of very high image quality 2
High-Risk Plaque Features
Beyond simple stenosis assessment, coronary CTA identifies high-risk plaque characteristics that provide incremental prognostic information 3, 4:
- Positive remodeling
- Low-attenuation plaque (lipid-rich)
- Spotty calcifications
- Napkin-ring sign
- Large plaque volume
These features are associated with increased risk of acute cardiovascular events and help stratify patients beyond traditional risk factors 3, 4.
Flow Assessment Capabilities
While traditional coronary CTA primarily evaluates anatomy, emerging technologies now enable functional flow assessment 5, 6:
- CT-derived fractional flow reserve (FFR-CT) assesses hemodynamic significance of stenoses
- CT stress perfusion evaluates myocardial perfusion
- These additions create a "one-stop-shop" for comprehensive anatomic and functional assessment 5
European and US evaluations show FFR-CT can reduce false positive diagnoses before invasive testing 1.
Clinical Implementation Algorithm
For patients with stable chest pain:
- First-line test: Coronary CTA (not functional stress testing) 1
- If plaque detected: Initiate preventive medical therapies regardless of stenosis severity 1
- If high-risk plaque features present: Consider more aggressive risk modification 3, 4
- If significant stenosis with uncertain hemodynamic significance: Consider FFR-CT or selective invasive angiography 1, 5
Common Pitfalls to Avoid
Do not order functional stress testing first in stable chest pain patients—this leads to significantly more cardiac catheterizations without improving outcomes 1. Nuclear SPECT imaging particularly drives unnecessary invasive procedures 1.
Do not dismiss non-obstructive plaque—the SCOT-HEART trial demonstrated that patient knowledge of plaque presence (even without significant stenosis) improves outcomes through lifestyle changes and preventive therapy 1.
Recognize image quality limitations—soft plaque characterization requires excellent image quality and may not be reliable in all clinical scenarios, particularly with heavy calcification, small vessels, or suboptimal studies 2.
Emerging Technologies
Photon-counting detector CT (PCD-CT) shows promise for improved stenosis grading in heavily calcified lesions 7. Additional emerging tools include fat attenuation index and artificial intelligence-based plaque quantification 3, 6, though these remain primarily investigational.